Nisa Investment Advisors
BBNX

Nisa Investment Advisors’s Beta Bionics BBNX Stock Holding History

Nisa Investment Advisors’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$621 Sell
62
-359
-85% -$5.31K ﹤0.01% 2830
2025
Q4 		$12.8K Buy
421
+333
+378% +$8.89K ﹤0.01% 2120
2025
Q3 		$1.75K Buy
88
+52
+144% +$914 ﹤0.01% 2646
2025
Q2 		$524 Buy
36
+21
+140% +$297 ﹤0.01% 2869
2025
Q1 		$184 Buy
+15
New +$280 ﹤0.01% 2933

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nisa Investment Advisors's BBNX Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Beta Bionics (BBNX) stake by 85% in Q1 2026, selling an estimated $5.31K and leaving 62 shares worth $621. The position accounts for ﹤0.01% of the portfolio, ranked #2830.

Nisa Investment Advisors first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $12.8K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Nisa Investment Advisors held 62 shares of Beta Bionics worth $621 as of Q1 2026.
  • Nisa Investment Advisors sold 359 Beta Bionics shares in Q1 2026, an estimated $5.31K.
  • Beta Bionics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2830 holding.
  • Nisa Investment Advisors first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Nisa Investment Advisors's Beta Bionics position peaked at $12.8K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.